1. Introduction

Single-cell omics technologies profile genomics, transcriptomics, proteomics, or other molecular features at the resolution of individual cells, uncovering heterogeneity masked by bulk analysis. Spatial omics adds locational context by mapping molecules within preserved tissue architecture. Multi-omics integration combines multiple data layers—such as transcriptomics with proteomics, epigenomics, or spatial information—from the same cells or tissue regions to generate comprehensive molecular maps. As of 2026, these methods document cellular states, tissue organization, and disease mechanisms in fields including oncology, immunology, and neuroscience.

2. Industry Overview and Market Data

The single-cell omics market was valued between USD 2.32 billion and USD 6.19 billion in 2025, with projections to 2030–2035 ranging from USD 3.45 billion (CAGR 11.1%) to USD 45.28 billion (CAGR 22.02%). Other estimates place 2025 values at USD 2.35–3.89 billion with CAGRs of 15.9–16.7% through 2030–2034.

The single-cell analysis market stood at USD 4.3 billion in 2024 and is estimated to reach approximately USD 5 billion in 2025, growing toward USD 20 billion by 2034 at a CAGR of 16.7%.

Spatial omics market estimates for 2025 range from USD 340–841 million, with forecasts to 2030–2034 between USD 1.70–3.36 billion at CAGRs of 9.5–16.62%.

Single-cell multi-omics segments show CAGRs of 18.3–24.5% in various reports, with one projecting growth from USD 3.18 billion in 2024 to USD 21.13 billion by 2035.

The broader multi-omics market was valued at USD 2.47–3.85 billion in 2025, projected to reach USD 6.73–12.65 billion by 2032–2035 at CAGRs of 15.09–15.4%.

North America consistently holds the largest share, while Asia-Pacific exhibits strong growth linked to large-scale genomics initiatives.

3. Core Technologies and Platforms

Single-Cell Omics Tools

• 10x Genomics Chromium: Droplet-based platform for high-throughput single-cell transcriptomics, multiome (RNA + ATAC), CITE-seq (RNA + protein), and immune profiling.
• Seurat (R-based) and Scanpy (Python-based): Widely used open-source pipelines supporting preprocessing, normalization, dimensionality reduction (PCA, UMAP), graph-based clustering (Louvain/Leiden), and integration of scRNA-seq, multiome, and CITE-seq datasets.

Spatial Omics Platforms

• 10x Genomics Visium (including Visium HD): Sequencing-based spatial transcriptomics on tissue sections, compatible with fresh-frozen and FFPE samples.
• 10x Genomics Xenium In Situ: High-plex, subcellular-resolution imaging-based platform for targeted or whole-transcriptome spatial profiling.
• Complementary methods include CosMx SMI (Bruker), MERFISH, and seqFISH for high-plex in situ detection.

Multi-Omics Integration Frameworks

• Tools such as totalVI, MOFA, scVI, and graph neural network approaches integrate transcriptomic, proteomic, epigenomic, and spatial data.
• Foundation models (e.g., scGPT) generate embeddings from large single-cell datasets for annotation, batch correction, and cross-omic inference.
• Spatial integration methods like Tangram (scRNA-seq to spatial mapping) and multimodal frameworks combine omics layers with histology or metabolomics.

4. Documented Advancements and Use Cases (2025–Early 2026)

• Multimodal and same-section integration: Innovations include VISTA-FISH for live-cell imaging on Xenium slides and MALDI-MSI paired with Xenium for combined spatial transcriptomics and metabolomics on the same tissue section. REFLEX enables TCR-seq with Flex chemistry.
• High-resolution spatial mapping: Platforms like CosMx Whole Transcriptome and RAEFISH achieve detection of 18,900–23,000 transcripts with subcellular resolution. Smart spatial omics (S2-omics) optimizes region-of-interest selection using histology-guided predictions.
• Computational and integration advances: Methods such as PathOmCLIP and GIST align histology with spatial transcriptomics via contrastive learning or 3D modeling. Nicheformer and DECIPHER analyze spatial cellular neighborhoods from millions of cells. SS pMosaic and MISO support resolution-agnostic deconvolution and multiscale integration.
• Workflow improvements: Single-cell multi-omics library preparation times reduced to under 10 hours on certain platforms. AI-assisted tools handle sparsity, batch effects, and cross-modal mapping in oncology, immunology, and tissue atlasing. Benchmarking datasets and standardization efforts (e.g., Spatial Touchstone) compare Xenium and CosMx performance across sites.

Experimental validation remains paired with computational predictions in iterative workflows.

5. Major Organizations and Platforms

Key entities include:

• 10x Genomics — Chromium (single-cell), Visium and Xenium (spatial), multiome capabilities.
• Bruker Spatial Biology — CosMx SMI platform.
• Open-source ecosystems: Seurat (Satija Lab), Scanpy/Squidpy (Theis Lab).
• Academic and industry groups developing foundation models and integration algorithms (e.g., scGPT, Tangram, BANKSY).

Many provide open datasets, code repositories, and APIs.

6. FAQ Section

Q: What distinguishes single-cell omics from spatial omics?A: Single-cell omics profiles dissociated cells at high molecular resolution; spatial omics retains positional information in intact tissue sections.

Q: Which data layers are typically combined in multi-omics integration?A: Transcriptomics, genomics (including ATAC-seq), proteomics (via CITE-seq), epigenomics, metabolomics, and spatial/histological data.

Q: What are the standard open-source analysis tools?A: Seurat (R) and Scanpy (Python) for single-cell and spatial data; packages like totalVI or MOFA for multi-omics integration.

Q: How do AI and computational methods support these technologies?A: Deep learning, graph neural networks, and foundation models address high-dimensional data, perform batch correction, impute missing values, enable cross-modal mapping, and support cell-type annotation or neighborhood analysis.

Q: Do computational predictions replace laboratory validation?A: No. Current practice integrates computational analysis with targeted experimental confirmation for functional and mechanistic insights.

Q: Which sample types are compatible with major spatial platforms?A: Fresh-frozen and formalin-fixed paraffin-embedded (FFPE) tissues, with platform-specific protocols and resolution varying by method (e.g., Visium and Xenium).

‍